FDA Drug Application (202144) for HYDROMORPHONE HYDROCHLORIDE by ACTAVIS LABS FL INC

Back to FDA Applications sponsored by ACTAVIS LABS FL INC

Application Number202144
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameHYDROMORPHONE HYDROCHLORIDE
Active IngredientHYDROMORPHONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROMORPHONE HYDROCHLORIDE5


Back to FDA Applications sponsored by ACTAVIS LABS FL INC